Day CP - Search Results

1

A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry.

Schwantes-An TH, Whitfield JB, Aithal GP, Atkinson SR, Bataller R, Botwin G, Chalasani NP, Cordell HJ, Daly AK, Darlay R, Day CP, Eyer F, Foroud T, Gawrieh S, Gleeson D, Goldman D, Haber PS, Jacquet JM, Lammert CS, Liang T, Liangpunsakul S, Masson S, Mathurin P, Moirand R, McQuillin A, Moreno C, Morgan MY, Mueller S, Müllhaupt B, Nagy LE, Nahon P, Nalpas B, Naveau S, Perney P, Pirmohamed M, Seitz HK, Soyka M, Stickel F, Thompson A, Thursz MR, Trépo E, Morgan TR, Seth D; GenomALC Consortium. Schwantes-An TH, et al. Among authors: day cp. Hepatol Commun. 2024 May 10;8(6):e0431. doi: 10.1097/HC9.0000000000000431. eCollection 2024 Jun 1. Hepatol Commun. 2024. PMID: 38727677 Free PMC article.

2

No evidence for involvement of type 1 collagen structural genes in 'genetic predisposition' to alcoholic cirrhosis.

Bashir R, Day CP, James OF, Ogilvie DJ, Sykes B, Bassendine MF. Bashir R, et al. Among authors: day cp. J Hepatol. 1992 Nov;16(3):316-9. doi: 10.1016/s0168-8278(05)80662-2. J Hepatol. 1992. PMID: 1362577

3

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.

Teli MR, Day CP, Burt AD, Bennett MK, James OF. Teli MR, et al. Among authors: day cp. Lancet. 1995 Oct 14;346(8981):987-90. doi: 10.1016/s0140-6736(95)91685-7. Lancet. 1995. PMID: 7475591

4

Alcohol--risks and mechanisms of damage.

Day CP. Day CP. J R Coll Physicians Lond. 1994 May-Jun;28(3):254-9. J R Coll Physicians Lond. 1994. PMID: 7932324 Free PMC article.

5

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.

Reeves HL, Burt AD, Wood S, Day CP. Reeves HL, et al. Among authors: day cp. J Hepatol. 1996 Nov;25(5):677-83. doi: 10.1016/s0168-8278(96)80238-8. J Hepatol. 1996. PMID: 8938545 Clinical Trial.

6

Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis.

Grove J, Daly AK, Bassendine MF, Day CP. Grove J, et al. Among authors: day cp. Hepatology. 1997 Jul;26(1):143-6. doi: 10.1002/hep.510260119. Hepatology. 1997. PMID: 9214463

7

Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance.

Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Day CP, et al. Diabetologia. 1998 Apr;41(4):430-4. doi: 10.1007/s001250050926. Diabetologia. 1998. PMID: 9562347

8

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

Smith BC, Gorve J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF. Smith BC, et al. Among authors: day cp. Hepatology. 1998 Jun;27(6):1695-9. doi: 10.1002/hep.510270631. Hepatology. 1998. PMID: 9620344

9

No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis.

Zappala F, Grove J, Watt FE, Daly AK, Day CP, Bassendine MF, Jones DE. Zappala F, et al. Among authors: day cp. J Hepatol. 1998 May;28(5):820-3. doi: 10.1016/s0168-8278(98)80232-8. J Hepatol. 1998. PMID: 9625317

10

The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype.

Grove J, Brown AS, Daly AK, Bassendine MF, James OF, Day CP. Grove J, et al. Among authors: day cp. Pharmacogenetics. 1998 Aug;8(4):335-42. doi: 10.1097/00008571-199808000-00007. Pharmacogenetics. 1998. PMID: 9731720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters